Home

Westend S.A.

CIK 1283968 · last filed 2024-03-25

Westend S.A. is a corporate insider who has filed 11 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider sold $795.0M of CAVA on Mar 25, 2024. Across all open-market trades the lifetime net is −$4.81B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.52B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.52B

Companies

6

Total Filings

11

Lifetime Open-Market Net

-$4.81B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CAVA Director 26,507,990 $82.24 $2.18B -$795.00M 2 2024-03-25
CRESCENT BIOPHARMA, INC. (GLYC) Delisted 10%+ Owner 8,589,064 $15.70 $134.85M $1.36M 1 2023-02-28
SRRK 10%+ Owner 8,850,005 $52.33 $463.12M $6.08M 1 2022-10-07
WTW 10%+ Owner 14,818,300 $261.50 $3.87B -$4.08B 5 2018-08-16
LXRX Director 2,130,717 $2.22 $4.73M $50.03M 1 2018-06-04
Ceres, Inc. (CERE) Delisted Director 4,192,167 $44.96 $188.48M $0 1 2012-11-13

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-03-25 CAVA Sell (S) −12,000,000 -$795.00M EDGAR
2023-06-22 CAVA Exer (M) +192,047,940 $0 EDGAR
2023-02-28 CRESCENT BIOPHARMA, INC. (GLYC) Delisted Buy (P) +800,000 $1.36M EDGAR
2022-10-07 SRRK Buy (P) +799,768 $6.08M EDGAR
2018-08-16 WTW Sell (S) −42,000,000 -$3.19B EDGAR
2018-06-04 LXRX Buy (P) +4,164,810 $50.03M EDGAR
2014-08-19 WTW Buy (P) +362,530 $8.47M EDGAR
2014-08-06 WTW Buy (P) +1,804,887 $38.96M EDGAR
2012-11-13 Ceres, Inc. (CERE) Delisted Other (J) +946,624 $4.58M EDGAR
2011-02-28 WTW Sell (S) −6,000,000 -$364.50M EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.